Recent Additions

Non-browning Pears by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:11 (3 months ago)
Date last modified: 2019/09/12 15:11 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Non-browning cherries by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (3 months ago)
Date last modified: 2019/09/12 15:10 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Optisochem by Bio Based Industry- Joint Undertaking (BBI-JU)
Biotech components: Enzyme + Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (3 months ago)
Date last modified: 2019/09/12 15:10 (3 months ago)
Known funding amount: 16,376,817 EUR
Funding types: Government + Private Funding
Industry: Energy + Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
crPhage by Locus Biosciences
Biotech components: Gene Editing + Molecule + Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (3 months ago)
Date last modified: 2019/09/12 15:10 (3 months ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salk Ideal Plants by Salk Institute for Biological Studies
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:08 (3 months ago)
Date last modified: 2019/09/12 15:08 (3 months ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Ecosystem Restoration + Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Engineered Tilapia by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:57 (3 months ago)
Date last modified: 2019/09/12 14:59 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 months ago)
Date last modified: 2019/09/12 14:53 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 months ago)
Date last modified: 2019/09/12 14:53 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Animal + Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 months ago)
Date last modified: 2019/09/12 14:53 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Ecosystem Restoration + Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Self-Limiting Medfly by Intrexon
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 months ago)
Date last modified: 2019/09/12 14:53 (3 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product